Key Dates

Related Announcements

RFA-HG-21-041 - New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)

PAR-22-181 - NCCIH, NEI, NIAAA, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)

NOT-EB-22-015 - Notice of NIBIB's Participation in PAR-22-181, " NCCIH, NEI, NIAAA, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)”

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform applicants that effective February 23, 2023, NIBIB will no longer be participating in RFA-HG-21-041 “New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional).”

Applicants who applied to this RFA and who wish to submit their unfunded project, may do so, but the application must be submitted as new application (not a resubmssion) to another FOA. https://grants.nih.gov/grants/policy/amendedapps.htm

Eligible Principal Investigators are encouraged to consider other opportunities such as PAR-22-181 for New and "At-Risk" Investigators to Promote Workforce Diversity.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact

Albert Avila, Ph.D.
National Institute of Biomedical Imaging and Bioengineering
Telephone: 301-496-8804
Email: [email protected]

Financial/Grants Management Contact

Ruthann McAndrew
National Institute Of Biomedical Imaging And Bioengineering (NIBIB)
Phone: 301-496-8521
E-mail: [email protected]